However, similar to what is observed in animal models of autoimmunity treated with Kv1.3 blockers, rats with a model of RA treated with a KCa1.1 blocker still exhibit signs of disease, but at lower levels than vehicle-treated animals [17, 21]. Here, KCNA3 is linked to rheumatoid arthritis.